104 related articles for article (PubMed ID: 12804790)
1. Neurodegeneration of substantia nigra accompanied with macrophage/microglia infiltration after intrastriatal hemorrhage.
Imamura N; Hida H; Aihara N; Ishida K; Kanda Y; Nishino H; Yamada K
Neurosci Res; 2003 Jul; 46(3):289-98. PubMed ID: 12804790
[TBL] [Abstract][Full Text] [Related]
2. Pathological dynamics of activated microglia following medial forebrain bundle transection.
Cho BP; Song DY; Sugama S; Shin DH; Shimizu Y; Kim SS; Kim YS; Joh TH
Glia; 2006 Jan; 53(1):92-102. PubMed ID: 16206155
[TBL] [Abstract][Full Text] [Related]
3. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
[TBL] [Abstract][Full Text] [Related]
4. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury.
Canudas AM; Pezzi S; Canals JM; Pallàs M; Alberch J
Brain Res Mol Brain Res; 2005 Mar; 134(1):147-54. PubMed ID: 15790538
[TBL] [Abstract][Full Text] [Related]
5. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat.
Mufson EJ; Kroin JS; Sobreviela T; Burke MA; Kordower JH; Penn RD; Miller JA
Exp Neurol; 1994 Sep; 129(1):15-26. PubMed ID: 7523178
[TBL] [Abstract][Full Text] [Related]
6. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine.
Rodrigues RW; Gomide VC; Chadi G
Int J Neurosci; 2001 Jul; 109(1-2):91-126. PubMed ID: 11699344
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
Porritt MJ; Batchelor PE; Howells DW
Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
[TBL] [Abstract][Full Text] [Related]
8. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease.
Depino AM; Earl C; Kaczmarczyk E; Ferrari C; Besedovsky H; del Rey A; Pitossi FJ; Oertel WH
Eur J Neurosci; 2003 Nov; 18(10):2731-42. PubMed ID: 14656322
[TBL] [Abstract][Full Text] [Related]
9. Microglial phagocytosis of dopamine neurons at early phases of apoptosis.
Cho BP; Sugama S; Shin DH; DeGiorgio LA; Kim SS; Kim YS; Lim SY; Park KC; Volpe BT; Cho S; Joh TH
Cell Mol Neurobiol; 2003 Oct; 23(4-5):551-60. PubMed ID: 14514015
[TBL] [Abstract][Full Text] [Related]
10. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
Aoi M; Date I; Tomita S; Ohmoto T
Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110
[TBL] [Abstract][Full Text] [Related]
11. Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation.
Yang YJ; Zhang S; Ding JH; Zhou F; Hu G
Int J Neuropsychopharmacol; 2009 Apr; 12(3):317-27. PubMed ID: 18700057
[TBL] [Abstract][Full Text] [Related]
12. Expression of BDNF mRNA in substantia nigra is dependent on target integrity and independent of neuronal activation.
Rite I; Venero JL; Tomás-Camardiel M; Machado A; Cano J
J Neurochem; 2003 Nov; 87(3):709-21. PubMed ID: 14535953
[TBL] [Abstract][Full Text] [Related]
13. Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway.
Aliaga E; Cárcamo C; Abarca J; Tapia-Arancibia L; Bustos G
Brain Res Mol Brain Res; 2000 Jun; 79(1-2):150-5. PubMed ID: 10925152
[TBL] [Abstract][Full Text] [Related]
14. Axotomy-induced dopaminergic neurodegeneration is accompanied with c-Jun phosphorylation and activation transcription factor 3 expression.
Song DY; Yang YC; Shin DH; Sugama S; Kim YS; Lee BH; Joh TH; Cho BP
Exp Neurol; 2008 Jan; 209(1):268-78. PubMed ID: 18036593
[TBL] [Abstract][Full Text] [Related]
15. Electro-acupuncture stimulation protects dopaminergic neurons from inflammation-mediated damage in medial forebrain bundle-transected rats.
Liu XY; Zhou HF; Pan YL; Liang XB; Niu DB; Xue B; Li FQ; He QH; Wang XH; Wang XM
Exp Neurol; 2004 Sep; 189(1):189-96. PubMed ID: 15296849
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Lu XG; Gao Q; Geller AI
Brain Res; 2005 Aug; 1052(2):119-29. PubMed ID: 16018990
[TBL] [Abstract][Full Text] [Related]
17. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
[TBL] [Abstract][Full Text] [Related]
18. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway.
Wu SY; Wang TF; Yu L; Jen CJ; Chuang JI; Wu FS; Wu CW; Kuo YM
Brain Behav Immun; 2011 Jan; 25(1):135-46. PubMed ID: 20851176
[TBL] [Abstract][Full Text] [Related]
19. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA
Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive study on long-term injury to nigral dopaminergic neurons following intracerebroventricular injection of lipopolysaccharide in rats.
Zhou Y; Zhang Y; Li J; Lv F; Zhao Y; Duan D; Xu Q
J Neurochem; 2012 Dec; 123(5):771-80. PubMed ID: 22957701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
